Dr. David F. Mcdermott
Overview
David Mcdermott is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Mcdermott is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
His clinical research consists of co-authoring 259 peer reviewed articles and participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 67 articles and participated in 8 clinical trials in the study of Melanoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
330 Brookline Avenue, Shapiro 9, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
16 Clinical Trials
The General Hospital Corporation
Keith Flaherty is an Oncologist in Boston, Massachusetts. Dr. Flaherty is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Melanoma of the Eye, Tissue Biopsy, and Nephrectomy. Dr. Flaherty is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Patrick Ott is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Ott is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Gastroesophageal Junction Cancer, Small Cell Lung Cancer (SCLC), Metastatic Uveal Melanoma, and Tissue Biopsy.
Dana-Farber Cancer Institute, Inc.
Elizabeth Buchbinder is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Buchbinder is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Vulvar Cancer, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MelanomaDr. Mcdermott isElite. Learn about Melanoma.
- Renal Cell Carcinoma (RCC)Dr. Mcdermott isElite. Learn about Renal Cell Carcinoma (RCC).
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Mcdermott isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Mcdermott isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Mcdermott isDistinguished. Learn about Familial Wilms Tumor 2.
- Lung CancerDr. Mcdermott isDistinguished. Learn about Lung Cancer.
- Wilms TumorDr. Mcdermott isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Mcdermott isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Bladder CancerDr. Mcdermott isAdvanced. Learn about Bladder Cancer.
- Familial Pancreatic CancerDr. Mcdermott isAdvanced. Learn about Familial Pancreatic Cancer.
- Muscle Invasive Bladder CancerDr. Mcdermott isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- NephrectomyDr. Mcdermott isAdvanced. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder CancerDr. Mcdermott isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Pleuropulmonary BlastomaDr. Mcdermott isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Mcdermott isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Mcdermott isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Mcdermott isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Breast CancerDr. Mcdermott isExperienced. Learn about Breast Cancer.
- Childhood Acute Myeloid LeukemiaDr. Mcdermott isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Mcdermott isExperienced. Learn about Chronic Myelogenous Leukemia (CML).